Biofrontera Inc. BFRI
0.85 USD -0.04 (-4.47%)
Nov 4, 2026, 3:49 PM EST
0.8453 Day range 0.93
0.555 52-week range 1.66
- YTD
- +49.14%
- 1 year
- -17.47%
Financial health
Altman Z-Score
-6.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 3
Valuation
P/E -0.5×
FY 2019 5y median -0.5× FY 2025
P/S 0.1×
FY 2019 5y median 0.2× FY 2025
P/B 0.6×
FY 2019 5y median 0.9× FY 2025
P/FCF -0.4×
FY 2019 5y median -0.6× FY 2025
EV/EBITDA -0.6×
FY 2019 5y median -0.5× FY 2025
EV/Sales 0.1×
FY 2019 5y median 0.1× FY 2025
FCF Yield -230.5%
FY 2019 5y median -171.8% FY 2025
Profitability
Gross Margin 78.7%
FY 2019 5y median 48.8% FY 2025
Operating Margin -21.9%
FY 2019 5y median -64.8% FY 2025
Net Margin -25.3%
FY 2019 5y median -47.6% FY 2025
ROE -100.5%
FY 2019 5y median -332.6% FY 2025
ROIC -53.8%
FY 2019 5y median -64.0% FY 2025
ROA -36.9%
FY 2019 5y median -70.9% FY 2025
Growth (YoY)
Revenue 11.8%
FY 2019 FY 2025
Operating Income 46.8%
FY 2019 FY 2025
EPS (diluted) 72.0%
FY 2019 FY 2025
Free Cash Flow -29.4%
FY 2019 FY 2025
Financial Health
Current Ratio 1.5×
FY 2019 5y median 1.7× FY 2025
Quick Ratio 1.4×
FY 2019 5y median 1.4× FY 2025
Debt / Equity 0.6×
FY 2019 5y median 0.6× FY 2025
Net Debt / EBITDA 0.0×
FY 2019 5y median 0.0× FY 2025
Interest Coverage -20.2×
FY 2019 5y median -37.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31